Atropos Health Raises $14M in Series A Funding
- Atropos Health, a Palo Alto, CA-based leader in providing physicians with research-grade real-world evidence at the point of care, closed a $14M Series A funding round
- The round was led by Breyer Capital with participation from Emerson Collective and Boston Millennia Partners
- In conjunction with the funding, Emerson Collective’s Matt Bettonville and Breyer Capital will have seats on the Atropos Health board of directors
- The company will use the funds to expand its commercial team, further build on recent market traction, and continue to develop its oncology product
- AtroposHealth is a developer of a physician consultation service powered by research-grade real-world data
- Using millions of anonymized patient records, the company helps providers answer clinical questions that have fallen through the cracks of the evidence-based literature
